Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 10, 1997, Pages 699-706

  Honda, Yayoi ^a   Minato, Hisao ^a   Fujitani, Buichi ^a   Masuda, Yoshinobu ^a   Hosoki, Kanoo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Angiotensin converting enzyme; Cerebral vasospasm; Endothelium dependent relaxation; Subarachnoid hemorrhage

Indexed keywords

ACETYLCHOLINE; ALACEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LINSIDOMINE; NITROPRUSSIDE SODIUM; PAPAVERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; BLOOD; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONTROLLED STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BASILAR ARTERY; CAPTOPRIL; DISEASE MODELS, ANIMAL; ENALAPRIL; ISCHEMIC ATTACK, TRANSIENT; MALE; MUSCLE RELAXATION; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 0031405574     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Takeyama, K., Minato, H., Fukuya, F., Kawahara, S., Hosoki, K., Kadokawa, T. Antihypertensive activity of alacepril, an orally active angiotensin-converting enzyme inhibitor, in renal hypertensive rats and dogs. Arzneim-Forsch/Drug Res 1985, 35: 1502-7.
2. Matsumoto, K., Miyazaki, H., Fujii, T., Yoshida, K., Amejima, H., Hashimoto, M. Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneim-Forsch/Drug Res 1986, 36: 40-6.
3. Masuda, Y., Nose, I., Honda, Y. et al. Alacepril attenuates reperfusion-induced cardiac disfunction by free radical scavenging effect via its sulfhydryl containing metabolites. desacetylalacepril and captopril. Jpn Pharmacol Ther 1989, 17: 203-13.
4. Kuwayama, A., Zervas, N.T., Belson, R., Shintani, A., Pickren, K. A model for experimental cerebral arterial spasm. Stroke 1972, 3: 49-56.
5. Brawley, B.W., Strandness, D.E. Jr., Kelly, W.A. The biphasic response of cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg 1968, 28: 1-8.
6. Nagai, H., Noda, S., Mabe, H. Experimental cerebral vasospasm. Part 2: Effects of vasoactive drugs and sympathectomy on early and late spasm. J Neurosurg 1975, 42: 420-8.
7. Honda, Y., Minato, H., Masuda, Y., Fujitani, B., Hosoki, K. Effect of (±)-(E)I-(3-fluoro-6,II-dihydrodibenz [b,e]-oxepine-II-yl)-4-(3-phenyl-2-propenyl)piperazine dimaleate on cerebral vasospasm and impairment of cerebral circulation in subarachnoid hemorrhage model in rats. Arzneim-Forsch/Drug Res 1996, 46: 746-50.
8. Espinosa, F., Weir, B., Boisvert, D., Overton, T., Castor, W. Chronic cerebral vasospasm after large subarachnoid hemorrhage in monkey, J Neurosurg 1982, 57: 224-32.
9. Delgado, T.J., Brismar, J., Svendgaard, N.A. Subarachnoid hemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985, 16: 595-602.
10. Zabramski, J.M., Spetzler, R.F., Bonstelle, C. Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model. Neurosurgery 1986, 18: 1-6.
11. Nakagomi, T., Kasell, N.F., Sasaki, T., Fujiwara, S., Lehman, R.M., Torner, J.C. Impairment of endothelium-dependent vasodilation induced by acetylcholine and triphosphate following experimental subarachnoid hemorrhage. Stroke 1987, 18: 482-9.
12. Debdi, M., Seylaz, J., Sercombe, R. Early changes in rabbit cerebral artery reactivity after subarachnoid hemorrhage. Stroke 1992, 23: 1154-62.
13. Steele, J.A., Stockbridge, N., Maljkovic, G., Weir, B. Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ Res 1991, 68: 416-23.
14. Watanabe, T, Asano, T., Shimizu, T., Seyama, Y., Takakura, K. Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem 1988, 50: 1145-50.
15. Shimizu, T., Watanabe, T., Asano, T., Seyama, Y, Takatura, K. Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachinoidal hemorrhage. J Neurochem 1988, 51: 1126-31.
16. ++ channel antagonist, AJ-3941. of loss of endothelium-dependent relaxation after subarachnoid hemorrhage in rats. Eur J Pharmacol 1996, 315: 297-303.
17. Matsui, T., Takuwa, Y., Johshita, H., Yamashita, K., Asano, T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral Vasospasm. J Cereb Blood Flow Metab 1991, 11: 143-9.
18. Rasmussen, H.,Takuwa, Y., Park, S. Protein kinase C in the regulation of smooth muscle contraction. FASEB 1987, 1: 177-85.
19. Bevan, J.A., Bevan, R.D. Arterial wall changes in chronic cerebrovasospasm: In vitro and in vivo pharmacological evidence. Ann Rev Pharmacol Toxicol 1988, 28: 311-29.
20. Kassell, N.F., Sasaki, T., Colohan, A.R.T., Nazar, G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985, 16: 562-72.
21. Matsui, T., Kaizu, H., Itoh, S., Asano, T. The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg 1994, 80: 276-82.
22. Martin, W., Villani, G.M, Jothianandan, D., Furchgott, R.F. Selective blockage of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985, 232: 708-16.
23. Rubanyl, G.M., Vanhoutte, P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986, 250: H822-7.
24. Someda, K., Morita, K., Kawamura, Y., Matsumura, H. Inti-inal change following subarachnoid hemorrhage resting in prolonged arterial luminal narrowing. Neurol Med Chir 1979, 19: 83-93.
25. Noda, Y., Mori, A., Packer, L. Free radical scavenging properties of alacepril metabolites and lisinopril. Res Commun Mol Pathol Pharmacol 1997, 96: 125-36.